A study published this month in the Journal of the American Veterinary Medical Association reports that cumulative omeprazole use in racehorses is linked to a modest increase in the incidence of exercise-induced pulmonary hemorrhaging (EIPH). Researchers analyzing Hong Kong racing records estimated that an 11% reduction in EIPH cases could theoretically occur if omeprazole administration were eliminated, though the study found no evidence linking the drug to fractures or atrial fibrillation.
Understanding the Link Between Omeprazole and EIPH
EIPH, commonly referred to as “bleeding,” occurs when lung capillaries rupture during strenuous exercise. According to the Journal of the American Veterinary Medical Association, researchers reviewed data from 2,924 horses across the 2012-13 and 2022-23 racing seasons in Hong Kong to determine if long-term proton pump inhibitor use contributed to this condition.
The study’s discussion notes that while the association between omeprazole and EIPH is not considered strong, the data indicates a clear hazard of detection linked to cumulative doses over a 30-day period. For a horse weighing approximately 1,060 to 1,100 pounds, the average daily dose observed was roughly 2 mg/kg/day.
Did you know?
Proton pump inhibitors like omeprazole are used for equine gastric ulcer syndrome, and the study was conducted because there have been no studies looking at the potential long-term physiological consequences of using the medication.
Dosage Variability and Clinical Implications
Clinical practices vary significantly regarding how omeprazole is administered. The study highlights that while some trainers use a 4 mg/kg dose, research suggests that doses as low as 1 mg/kg of enteric-coated omeprazole can be equally effective for treating squamous ulceration when given before exercise following a brief fast.
Researchers warned that the current data does not define a “safe” cumulative threshold for omeprazole use that guarantees the absence of EIPH risk. Furthermore, the study noted a “substantial predicted increase” in the probability of detecting EIPH in horses receiving the higher 4 mg/kg daily dosage.
Broader Health Impacts: Fractures and Atrial Fibrillation
Beyond EIPH and epistaxis—the visible presence of blood in the nostrils—the study examined potential correlations between omeprazole and other major equine health concerns, specifically fractures and atrial fibrillation. These conditions remain significant to the industry due to the high economic costs associated with lost training and racing time.
The analysis found no evidence of a relationship between omeprazole use and these two conditions. This distinction is significant because, in human medicine, proton pump inhibitors have been associated with an increased risk of fractures due to impaired calcium and magnesium absorption, as well as vitamin B12 deficiency. The equine study indicates that these specific human-side effects were not observed in the studied racehorse population.
Future Trends in Equine Gastric Management
Frequently Asked Questions
- What is EIPH in horses? EIPH stands for exercise-induced pulmonary hemorrhaging, a condition where the capillaries in a horse’s lungs rupture during high-intensity training or racing.
- Does omeprazole cause fractures in horses? The study published in the Journal of the American Veterinary Medical Association found no evidence linking omeprazole use to an increased risk of fractures in the horses studied.
- Is there a safe dose of omeprazole? The study did not identify a specific cumulative dose threshold that is entirely free of EIPH risk, though it noted that lower doses can be as effective as higher doses for treating gastric ulcers.
Have you observed changes in how your stable manages gastric health? Share your thoughts in the comments below or subscribe to our newsletter for the latest updates on equine veterinary research.
Related reading